First in Human Safety and Feasibility of a Novel Catheter Thrombectomy Device for the Treatment of Pulmonary Embolism (The ENGULF Trial)
Tai Kobayashi, M.D., FSCAI1, Eric Secemsky, MD, MSc, FSCAI2, Andrew J. Klein, M.D., FSCAI3, Salomao Faintuch, MD2, Julie C Bulman, MD2, Jeffrey L Weinstein, MD2, Yonatan Bitton-Faiwiszewski, MD, FSCAI4, Mohannad Bisharat, M.D.5, D. Chris Metzger, M.D.6, Russell D Rosenberg, M.D.7, Ido Weinberg, M.D.8, Venu Vadlamudi, MD9, William Matthai Jr., M.D.10, Amr Saleh, MD11, Ecaterina Cristea, MD12, Alexandra J. Lansky, M.D., MSCAI13 and Jay S. Giri, MD1, (1)Hospital of the University of Pennsylvania, Philadelphia, PA, (2)Beth Israel Deaconess Medical Center, Newton, MA, (3)Piedmont Heart Institute, Atlanta, GA, (4)Adventist Health St. Helena, Saint Helena, CA, (5)Ashchi Heart and Vascular Center, Jacksonville, FL, (6)OhioHealth Heart & Vascular Physicians, Dublin, OH, (7)University of Pennsylvania Health System, Wynnewood, PA, (8)Massachusetts General Hospital, Boston, MA, (9)Virginia Hospital Center, McLean, VA, (10)Presbyterian Hospital, Narberth, PA, (11)Yale University, Weston, CT, (12)Yale School of Medicine, New Haven, CT, (13)Yale University, New Haven, CT